Gremlin: A Novel Mediator of Epithelial Mesenchymal Transition and Fibrosis in Chronic Allograft Nephropathy

Transplantation Proceedings

Volumn 40, Issue 3, 2008, Pages 734-739

  Carvajal, G ^a   Droguett, A ^a   Burgos, M E ^a   Aros, C ^a   Ardiles, L ^a   Flores, C ^a   Carpio, D ^a   Ruiz Ortega, M ^b   Egido, J ^b   Mezzano, S ^a  

^a UNIVERSIDAD AUSTRAL DE CHILE   (Chile)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AZATHIOPRINE; CYCLOSPORIN A; CYTOKINE RECEPTOR ANTAGONIST; GREMLIN; OSTEOGENIC PROTEIN 1; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SOUTHWESTERN BLOTTING;

CELL DIFFERENTIATION; CHRONIC DISEASE; EPITHELIAL CELLS; FIBROSIS; HUMANS; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY TRANSPLANTATION; MESODERM; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS;

EID: 42949143822     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.02.064     Document Type: Article

References (20)

1. Roxburgh S.A., Murphy M., Pollock C.A., et al. Recapitulation of embryological programmes in renal fibrosis. The importance of epithelial cell plasticity and developmental genes. Nephron Physiol 103 (2006) 139
2. Kalluri R., and Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112 (2003) 1776
3. Liu Y. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism and therapeutic intervention. J Am Soc Nephrol 15 (2004) 1
4. Bottinger E., and Bitzer M. TGF-β signaling in renal disease. J Am Soc Nephrol 13 (2002) 2600
5. Fan J.M., Ng Y.Y., Hill P.A., et al. Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56 (1999) 1455
6. Merino R., Rodrigues-Leon J., Macias D., et al. The BMP antagonist Gremlin regulates otugrowth, chondrogenesis and programmed cell death in the developing limb. Development 126 (1999) 5515
7. Capdevila J., Tsukui T., Rodriguez-Esteban C., et al. Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin. Mol Cell 4 (1999) 839
8. Michos O., Panman L., Vintersten K., et al. Gremlin-mediated BMP antagonism induces the epithelial mesenchymal feedback signaling controlling metanephric kidney and limb organogenesis. Development 131 (2004) 3401
9. Lapin D., McMahon R., Murphy M., et al. Gremlin: an example of the re-emergence of developmetal programmes in diabetic nephropathy. Nephrol Dial Transplant 17 suppl 9 (2002) 67
10. McMahon R.A., Murphy M., Clarkson M., et al. IHG-2 a messangial cell gene induced by high glucose, is human gremlin. J Biol Chem 275 (2000) 9901
11. Mezzano S., Droguett M.A., Burgos M.E., et al. Expresión of Gremlin, bone morphogenetic protein antagonist, in glomerular crescents of pauci-inmune glomerulonephritis. Nephrol Dial Transplant 22 (2007) 1882
12. Murphy M., McMahon R.A., Murphy M., et al. Induction of gremlin expression in the remmanent kidney in vivo and during TGF-induced epithelial mesenchymal transformation in vitro. J Am Soc Nephrol 11 (2000) 625A
13. Mezzano S., Droguett A., Burgos M.E., et al. Overexpression of chemokines, fibrogenic cytokines and miofibroblasts in human membranous nephropathy. Kidney Int 57 (2000) 147
14. Lan H.Y. Tubular epithelial-myofibroblast transdifferentiation mechanisms in proximal tubule cells. Curr Opin Nephrol Hypertens 12 (2003) 25
15. Yang J., and Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159 (2001) 1465
16. Topol L., Bardot B., Zhangi Q., et al. Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J Biol Chem 275 (2000) 8785
17. Dolan V., Murphy M., Sadlier D., et al. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis 45 (2005) 1034
18. Bariety J., Bruneval P., Hill G.S., et al. Transdifferentiation of epithelial glomerular cells. J Am Soc Nephrol 14 suppl 1 (2003) S42
19. Koli K., Myllarniemi M., and Vuorinen K. Bone morphogenetic protein 4 inhibitor Gremlin overexpressed in idiophatic pulmonary fibrosis. Am J Pathol 169 (2006) 61
20. Boers W., Aarrass S., Linthorst C., et al. Transcriptional profiling reveals novel markers of liver fibrogenesis. Gremlin and insulin-like growth factor-binding proteins. J Biol Chem 281 (2006) 16289